Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$1114b Graphic](https://lunarcrush.com/gi/w:26/t:$1114b.png) $1114b

$ABT stock dips despite strong earnings and revenue. Investors react to trimmed future guidance, despite positive financial results.

### About $1114b
This report summarizes social media activity and engagement related to the topic $1114b, which appears to be related to Abbott Laboratories (ABT) earnings.  

### Insights [#](/topic/$1114b/insights)
- $1114b creators is up XXXXX% from the previous week.
- $1114b mentions is up XXXXX% from the previous week.
- $1114b Creators hit a high of XX for the day
- $1114b Creators hit an all time of XX for the day
- $1114b Mentions hit a high of XX for the day
- $1114b Mentions hit an all time of XX for the day

### Engagements: XXXXX [#](/topic/$1114b/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$1114b/c:line/m:interactions.svg)  
[Engagements 24-Hour Chart Data](/topic/$1114b/time-series/interactions.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XXXXX  
**1 Month**: XXXXXX -XX%  
**1-Year High**: XXXXXXX on 2025-05-29  
**1-Year Low**: X on 2025-06-18  

| Social Network | X     |
| -------------- | -     |
| Engagements    | XXXXX |
  

  
  
### Mentions: XX [#](/topic/$1114b/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$1114b/c:line/m:posts_active.svg)  
[Mentions 24-Hour Chart Data](/topic/$1114b/time-series/posts_active.tsv)  
**Current Value**: XX  
**Daily Average**: X  
**1 Week**: XX +2,400%  
**1 Month**: XX +200%  
**1-Year High**: XX on 2025-07-18  
**1-Year Low**: X on 2025-05-08  

| Social Network | X  |
| -------------- | -  |
| Mentions       | XX |
  

  
  
### Creators: XX [#](/topic/$1114b/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$1114b/c:line/m:contributors_active.svg)  
[Creators 24-Hour Chart Data](/topic/$1114b/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning $1114b in the last XX hours which is down XXXX% from XX in the previous XX hours
**Daily Average**: X  
**1 Week**: XX +2,300%  
**1 Month**: XX +190%  
**1-Year High**: XX on 2025-07-18  
**1-Year Low**: X on 2025-05-08  

The most influential creators that mention $1114b in the last XX hours

| Creator                                          | Rank | Followers | Posts | Engagements |
| -------                                          | ---- | --------- | ----- | ----------- |
| [@Earnings_Time](/creator/twitter/Earnings_Time) | X    | XXXXX     | X     | XXX         |

[View More](/list/creators/$1114b/100)
  
  
### Sentiment: XX% [#](/topic/$1114b/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$1114b/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/$1114b/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1-Year High**: XXX% on 2025-07-17  
**1-Year Low**: XX% on 2025-07-18  

**Most Supportive Themes**
- **Increased Activity:** (50%) Mentions of $1114b are up, indicating increased interest, and creator activity is also up, showing growing community engagement.
  
**Most Critical Themes**
- **Guidance Cut:** (50%)  Abbott Laboratories (ABT) stock is down, despite beating earnings and revenue expectations, due to a trimmed full-year 2025 guidance.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXX      | XX% | XXX     | XX% | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXX      | XX% | XXX     | XX% | X        | X% |
  


**Top assets mentioned**
In the posts about $1114b in the last XX hours

[Arcblock (ABT)](/topic/$abt)
[Abbott Laboratories (ABT)](/topic/abbott-laboratories)

**Top topics mentioned**
In the posts about $1114b in the last XX hours

[$abt](/topic/$abt), [eps](/topic/eps), [$1106b](/topic/$1106b), [abbott laboratories](/topic/abbott-laboratories), [$1102b](/topic/$1102b), [rev](/topic/rev), [libre](/topic/libre), [coins ai](/topic/coins-ai), [stockmarket](/topic/stockmarket), [stocks healthcare](/topic/stocks-healthcare), [stocks](/topic/stocks), [$80m](/topic/$80m), [cmg](/topic/cmg), [$178b](/topic/$178b), [$3007b](/topic/$3007b), [$125reports](/topic/$125reports), [nutrition](/topic/nutrition), [investment](/topic/investment), [fund manager](/topic/fund-manager), [athens](/topic/athens), [bharat](/topic/bharat), [$331b](/topic/$331b), [$379b](/topic/$379b), [$431b](/topic/$431b), [l3harris technologies](/topic/l3harris-technologies), [fri](/topic/fri), [fed](/topic/fed), [empire](/topic/empire), [inflation](/topic/inflation), [$55m](/topic/$55m), [china](/topic/china), [scan](/topic/scan), [$2552m](/topic/$2552m)

### Top Social Posts [#](/topic/$1114b/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$ABT : -XXXX% despite double beat on earnings & good sales as profit forecasts were trimmed EPS: $XXXX vs. $XXXX est. Revenue: $11.14B vs. $11.06B est"  
[@EtCrypto20](/creator/x/EtCrypto20) on [X](/post/tweet/1946143250416533969) 2025-07-18 09:41:23 UTC XX followers, XX engagements


"$ABT has released its Q2 2025 earnings where EPS of $XXXX met expectations while revenue reached $11.14B reflecting a XXXX% year-over-year increase. Despite a XXX% decline in diagnostics sales particularly in COVID testing other divisions showed resilience with medical devices growing by 12%. Key risks include ongoing headwinds from COVID impacts and geopolitical issues in China. Future opportunities hinge on product advancements especially in diabetes care and biosimilars. 📊✨ For more details check"  
[@value_verge](/creator/x/value_verge) on [X](/post/tweet/1946059719610929424) 2025-07-18 04:09:27 UTC XX followers, XX engagements


"Stock Market Update S&P XXX lagging stock $ABT -XXXX% Q2 EPS: $XXXX vs $XXXX est Revenue: $11.14B (+7.4% YoY) beat Medical Devices: +13% overall COVID testing rev: -XX% YoY ($55M) FY EPS guide: $5.10$5.20 vs $XXXX est Worst day since 2021 Not a recommendation"  
[@LiberatorTrades](/creator/x/LiberatorTrades) on [X](/post/tweet/1946038716151255274) 2025-07-18 02:46:00 UTC XX followers, XX engagements


"🚨 $ABT Abbott Laboratories earnings results 💥 EPS: $XXXX vs. $XXXX est. (+0.80%) ✅ Revenue: $11.14B vs. $11.02B est. (+1.08%) ✅ #Earnings #StockMarket"  
[@ScpFundamental](/creator/x/ScpFundamental) on [X](/post/tweet/1945861633462390970) 2025-07-17 15:02:20 UTC XX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$1114b Graphic $1114b

$ABT stock dips despite strong earnings and revenue. Investors react to trimmed future guidance, despite positive financial results.

About $1114b

This report summarizes social media activity and engagement related to the topic $1114b, which appears to be related to Abbott Laboratories (ABT) earnings.

Insights #

  • $1114b creators is up XXXXX% from the previous week.
  • $1114b mentions is up XXXXX% from the previous week.
  • $1114b Creators hit a high of XX for the day
  • $1114b Creators hit an all time of XX for the day
  • $1114b Mentions hit a high of XX for the day
  • $1114b Mentions hit an all time of XX for the day

Engagements: XXXXX #


Engagements Line Chart
Engagements 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XXXXX
1 Month: XXXXXX -XX%
1-Year High: XXXXXXX on 2025-05-29
1-Year Low: X on 2025-06-18

Social Network X
Engagements XXXXX

Mentions: XX #


Mentions Line Chart
Mentions 24-Hour Chart Data
Current Value: XX
Daily Average: X
1 Week: XX +2,400%
1 Month: XX +200%
1-Year High: XX on 2025-07-18
1-Year Low: X on 2025-05-08

Social Network X
Mentions XX

Creators: XX #


Creators Line Chart
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning $1114b in the last XX hours which is down XXXX% from XX in the previous XX hours Daily Average: X
1 Week: XX +2,300%
1 Month: XX +190%
1-Year High: XX on 2025-07-18
1-Year Low: X on 2025-05-08

The most influential creators that mention $1114b in the last XX hours

Creator Rank Followers Posts Engagements
@Earnings_Time X XXXXX X XXX

View More

Sentiment: XX% #


Sentiment Line Chart
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1-Year High: XXX% on 2025-07-17
1-Year Low: XX% on 2025-07-18

Most Supportive Themes

  • Increased Activity: (50%) Mentions of $1114b are up, indicating increased interest, and creator activity is also up, showing growing community engagement.

Most Critical Themes

  • Guidance Cut: (50%) Abbott Laboratories (ABT) stock is down, despite beating earnings and revenue expectations, due to a trimmed full-year 2025 guidance.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXX XX% XXX XX% X X%
Total XXX XX% XXX XX% X X%

Top assets mentioned In the posts about $1114b in the last XX hours

Arcblock (ABT) Abbott Laboratories (ABT)

Top topics mentioned In the posts about $1114b in the last XX hours

$abt, eps, $1106b, abbott laboratories, $1102b, rev, libre, coins ai, stockmarket, stocks healthcare, stocks, $80m, cmg, $178b, $3007b, $125reports, nutrition, investment, fund manager, athens, bharat, $331b, $379b, $431b, l3harris technologies, fri, fed, empire, inflation, $55m, china, scan, $2552m

Top Social Posts #


Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"$ABT : -XXXX% despite double beat on earnings & good sales as profit forecasts were trimmed EPS: $XXXX vs. $XXXX est. Revenue: $11.14B vs. $11.06B est"
@EtCrypto20 on X 2025-07-18 09:41:23 UTC XX followers, XX engagements

"$ABT has released its Q2 2025 earnings where EPS of $XXXX met expectations while revenue reached $11.14B reflecting a XXXX% year-over-year increase. Despite a XXX% decline in diagnostics sales particularly in COVID testing other divisions showed resilience with medical devices growing by 12%. Key risks include ongoing headwinds from COVID impacts and geopolitical issues in China. Future opportunities hinge on product advancements especially in diabetes care and biosimilars. 📊✨ For more details check"
@value_verge on X 2025-07-18 04:09:27 UTC XX followers, XX engagements

"Stock Market Update S&P XXX lagging stock $ABT -XXXX% Q2 EPS: $XXXX vs $XXXX est Revenue: $11.14B (+7.4% YoY) beat Medical Devices: +13% overall COVID testing rev: -XX% YoY ($55M) FY EPS guide: $5.10$5.20 vs $XXXX est Worst day since 2021 Not a recommendation"
@LiberatorTrades on X 2025-07-18 02:46:00 UTC XX followers, XX engagements

"🚨 $ABT Abbott Laboratories earnings results 💥 EPS: $XXXX vs. $XXXX est. (+0.80%) ✅ Revenue: $11.14B vs. $11.02B est. (+1.08%) ✅ #Earnings #StockMarket"
@ScpFundamental on X 2025-07-17 15:02:20 UTC XX followers, XXX engagements

$1114b
/topic/$1114b